Patients | Classification | Age at onset of treatment (months) | Before treatment | After treatment | |||||
---|---|---|---|---|---|---|---|---|---|
Testes position | Penile length (mm) | Time to descent (months) | Testes volume (ml) | Testes position | Penile length (mm) | Duration of treatment (months) | |||
P1 | CPHD | 6 | Non palpable | 18 | 1 | 0.61 | High scrotal | 30 | 6 |
P2 | CPHD | 11 | Non palpable | 20 | 4 | 2 | Intra-scrotal | 33 | 6 |
P3 | CPHD | 10 | High-scrotal | 30 | 1 | 2,1 | Intra-scrotal | 70 | 6 |
P4 | IHH | 4.5 | Non palpable | 21 | 4 | 0.76 | Intra-scrotal | 30 | 6.5 |
P5 | IHH | 2.5 | Non palpable | 20 | 6 | 0.7 | High-scrotal Intra-scrotal | 35 | 6.5 |
P6 | IHH | 9 | Non palpable | 19 | 4 | 1,16 | Intra-scrotal | 40 | 5 |
P7 | IHH | 5 | High-scrotal | 28 | 4 | 0,89 | Intra-scrotal | 52 | 5 |
P8 | IHH | 0.25 | High-scrotal | 13 | 5 | 1,95 | Intra-scrotal | 30 | 6 |